Oxandrolone is use to promote weight gain following weight loss associated with extensive surgery, chronic infections, or severe trauma, and in select patients who fail to gain or maintain normal weight. It is also use to counter chronic corticosteroid-induced protein catabolism and for relief of bone pain associated with osteoporosis.
Oxandrolone has been developed from DHT (Dihydrotestosterone) to be taken orally and the way it has been modified allows it to metabolize through the liver without causing a dangerous toxic effect.
Oxandrolone may be habit forming, thus never share oxandrolone with another person, especially someone with a history of drug abuse or addiction. Keep the medication in a place where others cannot get to it.
Since, Cholestatic hepatitis and jaundice may occur with 17-alpha-alkylated androgens at a relatively low dose. If cholestatic hepatitis with jaundice appears or if liver function tests become abnormal. Then, Oxandrolone should be discontinued and the etiology should be determined. And then drug induced jaundice is reversible when the medication is discontinued.
Since, androgenic anabolic steroids have been reported to increase low density lipoproteins and decrease high density lipoproteins. Hence, caution is required when administering these agents to patients with a history of cardiovascular disease or who are at risk for cardiovascular disease. Thus, serum determination of lipid levels should be performed periodically and therapy adjusted accordingly.
Oxandrolone is a drug of abuse and you should be aware if anyone is using your medicine improperly or without a prescription. Store at room temperature away from moisture and heat. Keep track of the amount of medicine used from each new bottle.
Oxandrolone will not enhance athletic performance and should not be used for that purpose.
For men using Oxandrolone alone, which isn't recommended, it would need to be at a fairly high dose to bring about any noticeable results. It can cause bone overgrowth in children, especially young children. Bone development may need to be checked with x-rays every 6 months during treatment.